ADVERTISEMENT
|
|
Top Stories
Shareholders have approved the issuance of Bristol-Myers Squibb common stock for the pending $74-billion merger with Celgene.
/ read more /
Catalent’s acquisition of Paragon Bioservices will provide expertise in expanding gene therapy market.
/ read more /
|
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
The partnership includes a $10,000 donation to fund Illinois Biotechnology Innovation Organization (iBIO) STEM programming for girls in grades three through eight.
/ read more /
The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.
/ read more /
More Industry News
|
|
|
|
Biopharma News
With the spin-off, Alcon will operate as a standalone company, and Novartis will focus on its core innovative medicines.
/ read more /
Concerto HealthAI’s real-world data and artificial intelligence capabilities are expected to accelerate outcomes studies and patient insights for Pfizer’s investigational therapies and commercialized therapeutics.
/ read more /
More Biopharma News
|
|
|
|
Supplier News
The new service offers a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of gene and cell therapies.
/ read more /
|
|
|
Legacy Pharmaceuticals has entered into a collaboration with SCHOTT to solve a technical challenge of leaching that is occurring with an antiviral drug.
/ read more /
More Supplier News
|
|
|
Regulatory News
The European Medicines Agency (EMA) weighs in on the role of regulators in determining added benefits of novel therapies.
/ read more /
|
|
|
Brexit has the potential to rumble on until Oct. 31, 2019 as the UK is granted a further six-month extension by European Union leaders.
/ read more /
More Regulatory News
|
|
|
ADVERTISEMENT
2019 BIO International Convention
June 3-6, 2019 | Philadelphia, PA
As the world's largest global biotechnology partnering event, the BIO International Convention (#BIO2019) is the one event where you can access 16,000+ attendees from 67 countries, network and set up meetings via BIO One-on-One Partnering™, and attend 150+ education sessions. Discover the next generation of cutting-edge products, therapies, and cures all week long.
Learn More »
|
|
|
|
FEATURED TOPICS |
BIOPHARMACEUTICAL ANALYSIS
Laboratory test methods evaluate cleaning agents and cleaning process design for removing resin residues from the surfaces of non-dedicated chromatography columns systems.
/ read more /
|
|
|
|
DOWNSTREAM PROCESSING
The latest advances in downstream processing include remote monitoring, membrane chromatography technology, single-use sensors, and new uses of data analytics.
/ read more /
|
|
|
|
DRUG DEVELOPMENT
A look at the skill sets and training needed to tackle the increasing levels of automation in bioprocessing facilities.
/ read more /
|
|
|
|
ADVERTISEMENT
Register for the free live webcast “Sustainable Sourcing and Supply Chain Engagement in Pharma.”
Various aspects of the pharma sourcing process and supplier relationships offer opportunities to advance sustainability and strategic goals. These include alternative raw materials at manufacturing facilities (e.g., biomass and recycled plastic), sourcing of renewable materials (e.g., palm oil), partnering on supplier sustainability, and more. This May 7 event is sponsored by BASF, Sustainable Brands, and Pharmaceutical Technology.
Register Now »
|
|
|
|
CPhI NORTH AMERICA 2019 EXHIBITOR GUIDE
|
BioReliance® End-to-End Solutions encompass service and support for both emerging biotech as well as major biopharmaceutical companies that seek to accelerate process development, clinical drug production, and conceptual facilities design. / read more /
|
|
Thermo Fisher Scientific provides end-to-end development and manufacturing solutions to customers of all sizes through Patheon and Fisher Clinical Services, which deliver pharma services and clinical trials services. / read more /
|
|
USP’s Ingredient Verification Program for Excipients includes a complete evaluation of your quality system. / read more /
|
NEW PRODUCTS AND SERVICES
|
Distek, a manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry, has added a dual impeller single-use bioreactor system to its BIOne portfolio. / read more /
|
|
UPCOMING WEBCASTS
Characterizing CQAs of Biopharmaceutical Products: A Comprehensive Workflow Approach to Common Biopharmaceutical Tests
US and Europe: Wednesday, April 24, 2019 at 9am EDT | 2pm BST | 3pm CEST
US: Wednesday, April 24, 2019 at 2pm EDT | 1pm CDT | 11am PDT
Asia-Pacific: Thursday, April 25, 2019 at 8:30am IST | 11am CST | 12pm JST
Register Now
Approaches to Analyze and Understand 1–100 µm Particles/Aggregates in Biotherapeutics
Tuesday, April 23, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Direct Identification of Contaminant Particles on Lyophilization Cakes
Thursday, April 18, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Approaches to mAb Charge Variant Characterization using On-Line CEX-MS and Off-Line Analysis of CEX Purified Variants
Wednesday, April 17, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
|
|
Events
April 14–17, 2019
April 30–May 2, 2019
May 15–16, 2019
more events
|
|
|
eBook
|
This eBook covers method development, analytical techniques, and profiles of new instruments, equipment, and supplies used in the testing and analysis of raw materials, drug substances, and drug products.
|
|
|
|
|
|